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Abstract: The marine brown alga Dictyota pfaffii from Atol das Rocas, in Northeast Brazil 
is a rich source of dolabellane diterpene, which has the potential to be used in future 
antiviral drugs by inhibiting reverse transcriptase (RT) of HIV-1. Reexamination  
of the minor diterpene constituents yielded three new dolabellane diterpenes, 
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(1R*,2E,4R*,7S,10S*,11S*,12R*)10,18-diacetoxy-7-hydroxy-2,8(17)-dolabelladiene (1), 
(1R*,2E,4R*,7R*,10S*,11S*,12R*)10,18-diacetoxy-7-hydroxy-2,8(17)-dolabelladiene (2), 
(1R*,2E,4R*,8E,10S*,11S,12R*)10,18-diacetoxy-7-hydroxy-2,8-dolabelladiene (3), termed 
dolabelladienols A–C (1–3) respectively, in addition to the known dolabellane diterpenes  
(4–6). The elucidation of the compounds 1–3 was assigned by 1D and 2D NMR, MS, 
optical rotation and molecular modeling, along with the relative configuration of compound 
4 and the absolute configuration of 5 by X-ray diffraction. The potent anti-HIV-1 activities 
displayed by compounds 1 and 2 (IC50 = 2.9 and 4.1 μM), which were more active than 
even the known dolabelladienetriol 4, and the low cytotoxic activity against MT-2 
lymphocyte tumor cells indicated that these compounds are promising anti-HIV-1 agents. 
Keywords: marine natural products; Dictyota pfaffii; dolabellane diterpenes; anti-HIV-1 
 
1. Introduction 
Human immunodeficiency virus (HIV) remains a cause of worldwide concern. According to the 
WHO and UNAIDS in October 2013, approximately 35.3 million people were infected with HIV.  
In 2012, approximately 1.6 million people died of AIDS-related causes. Since the introduction of  
the highly active anti-retroviral therapy (HAART), the life expectancy of HIV-infected individuals  
has increased, even in cases in which the virus remains active [1]. However, the discovery and 
development of new drugs candidates is required, as current drugs do not completely eradicate HIV 
from infected tissues and the long-term use of these drugs is restricted by the emergence of drug-resistant 
viruses, metabolic disorders and toxicity [1,2]. Of the several classes of anti-HIV compounds, inhibitors 
of reverse transcriptase are considered one of the most successful compounds in clinical use. Research 
has proven marine organisms to be excellent sources of biologically active compounds with the 
potential to combat HIV [1]. In particular, terpenoids isolated from marine algae [1,3,4] have been 
described as anti-HIV-1 inhibitors. 
Mechanisms of action include the blocking of different steps of the HIV-1 replicative cycle as entry 
inhibitors [5,6], reverse transcriptase inhibitors [1,5] or protease inhibitors [1,7]. More particularly, 
diterpenes isolated from marine alga represent one of the most active and promising compounds in the 
development of new drugs to control HIV-1 during the infective process [1,8]. In our search for new 
anti-HIV compounds from marine sources, we have identified a dolabellane diterpene from the brown 
seaweed Dictyota pfaffii Schnetter (Dictyotaceae, Phaeophyceae) with strong anti-HIV-1 activity.  
Due to the highly relevant results obtained thus far, we further investigated the anti-HIV inhibiting 
capacities of the minor dolabellane diterpenes. Moreover, dolabellane diterpenes demonstrate a wide array 
of interesting pharmacological properties such as antibacterial [9], antiprotozoal [10], antifungal [11], 
anti-inflammatory [12] and antimalarial [13] activities. We found one such dolabellane diterpene, 
dolabelladienetriol, to be a non-competitive inhibitor of HIV-1 reverse transcriptase [2,14,15]. In this 
paper we report the isolation and structural determination of three new dolabellane diterpenes 1–3, 
(Figure 1), as will be demonstrated, two of these compound, 1 and 2, exhibited potent antiviral activity. 
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Figure 1. Structure of the new dolabellane diterpenoids dolabelladienols A–C (1–3), along 
with the known dolabelladienetriol (4–6) isolated from D. pfaffii. 
 
2. Results and Discussion 
Specimens of D. pfaffii were collected during scuba dives (6–9 m) at Atol das Rocas reef,  
Rio Grande do Norte State, the only atol in the South Atlantic, and were subsequently air-dried.  
In order to obtain 3.5 g of organic residue, the material was extracted exhaustively with CH2Cl2, 
filtered and solvent removed under vacuum at 40 °C. The resulting extract was fractionated by vacuum 
column chromatography (VC) and subjected to successive silica gel column chromatographies (CC)  
in order to afford pure compounds 1–6. 
2.1. Structural Elucidation 
Compound 1 (28 mg) was isolated as a white solid. EIMS analysis (m/z 406 [M]
+
) and 
13
C NMR 
spectra, which was confirmed by the observation of a [M + Na]
+
 peak at m/z 429.2631 in its  
(+)-HRESIMS suggested the molecular formula of C24H38O5 (six degrees of unsaturation) for compound 1. 
The 
13
C NMR data of 1 (Table 1) showed the presence of 24 carbon signals, which were assigned, 
using an APT experiment, as six methyls, six methylenes (five sp
3
 and one sp
2
), seven methines (two 
sp
3
 and five sp
2
) and five quaternary carbons (three sp
3
 and two sp
2
). A detailed analysis of 1D and 2D 
NMR spectra determined the gross structure of 1 (Supplementary Figures S1–S6). The presence of two 
acetate residues were easily deduced from the ester carbonyl signals at δC 170.5 and 170.1, along with 
two methyl groups at δH 2.04 (s, 3H) and 1.93 (s, 3H). Therefore, we inferred the diterpene structure  
of 1 from the 20 carbons after subtraction of the four carbons associated with two acetate groups. The 
presence of two oxygenated methines were deduced from NMR signals at δC 70.2 which was coupled 
via HSQC with the proton signal at δH 4.37 (dd, J = 8.4, 3.5 Hz) and at δC 68.6 correlated with the 
proton signal at δH 4.91 (ddd, J = 8.9, 4.7, 2.4 Hz) which was assigned to an hydroxymethine and an 
acetoxy-bearing methine, respectively. The methlylene carbon NMR signal observed at δC 113.4 which 
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correlated according to HMBC with the olefinic methylene protons at δH 5.12 (1H, brs) and 4.99 (1H, brs), 
along with olefinic quaternary carbon at δC 146.2, indicated the existence of an exocyclic double bond. 
The existence of disubstituted double bond with an E configuration in 1 was inferred by the proton 
signals at δH 5.66 (dd, J = 16.4, 7.2 Hz) and 5.17 (d, J = 16.4 Hz), which correlated according to 
HMBC with the sp
2
 carbons at δC 133.6 and 137.5. The quaternary signal at δC 84.8, characteristic of  
a bearing acetoxy quaternary carbon, along with the methyl singlets at δH 1.60 (s, 3H), 1.42 (s, 3H) 
were indicative of the presence of a 2-propan-2-yl acetate group [15]. Furthermore, the NMR data of  
1 (Table 1) displayed an additional two methyl groups at δH 0.97 (d, J = 6.9 Hz, 3H)/δC 22.2 and  
δH 0.83 (s, 3H)/δC 16.8. The above-presented NMR data closely resemble those for bicyclic 
dolabellane skeleton, which were established as taxonomic markers for this alga [16]. However, 
differences in the chemical shifts as a result of the unsaturation and oxygenation pattern indicated of  
a new natural product. Two main proton spin systems, outlined in Figure 2a, were established by  
1
H-
1
H COSY experiments after assignments of the direct 
1
H-
13
C correlations via HSQC analysis. 
The first spin system was identified by 
1
H-
1
H COSY correlations between the olefinic proton at  
δH 5.17 (H-2) and the hydroxymethyne at δH 4.37, (H-7). A second was recognized by correlating the 
methylene protons at δH 2.43 and 2.46 (H-9) with those at δH 1.46 and 1.39 (H-14). Analysis of the 
HMBC spectrum granted the connectivity of these two spin-systems. The observed correlations between 
the methylene olefinic protons H-17a (δH 5.12, brs) and H-17b (δH 4.99, brs) and the oxygenated 
methine C-7 (δc 70.2) and methylene C-9 (δc 41.0) allowed for the connection of the exocyclic double 
bond Δ8(17) to both spin systems. On the other hand, HMBC cross-peaks between the olefinic  
H-2 (δH 5.17, d, J = 16.4 Hz), the methylene H2-14 (δH 1.46, m) and H-11 (δH 1.84, dd, J = 10.8,  
2.4 Hz) protons with the methyl carbon C-15 (δC 16.8) confirmed the bicyclic dolabelladiene structure 
presented in Figure 2a. The location of the acetate group at C-10 was established through the HMBC 
correlations between H-10 (δH 4.91, ddd, J = 8.9, 4.7, 2.4 Hz) and H3-24 (δH 1.93, s) protons and the 
carbonyl signal at δC 170.1 (C-23). 
We demonstrated the assignment of the 2-propan-2-yl acetate group to position 12 by was the long 
range 
1
H-
13
C coupling of the methine proton H-12 at 2.95 (td, 10.8, 4.7) with methyl singlets C-18 and 
C-20 at δC 23.4 and 26.4 (Figure 2a). Therefore, on the basis of the above analysis, we established the 
planar structure of 1 as illustrated in Figure 2a. Having established the planar structure of dolabellane 1, 
we focused our attention on its stereochemistry. Key NOESY correlations observed between methyl 
protons H3-15, H-12 and H-10, and this in turn to H-7, led to the conclusion that protons H3-15, H-12, 
H-10 and H-7 are on the same side of the bicyclic ring (Figure 3a) and further suggested a 1R*, 7S*, 
10S* and 12R* relative configuration. In order to confirm these stereochemical assignments,  
a conformational space of the two possible 7R*- or 7S*-epimers was explored using the GMMX 
stochastic conformational search procedure as implemented in the program PC-MODEL, which itself 
used an MMX force field. 
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Table 1. 
13
C and 
1
H NMR data (500 MHz in CDCl3) of dolabelladienols A–C (1–3) (δ in 
ppm, J in Hz). 
Position 
1 2 3 
δC δH δC δH δC δH 
1 48.4 - 48.1 - 48.9 - 
2 137.5 5.17 (d, 16.4) 138.9 5.24 (d, 16.4) 136.9 5.23 (dd, 16.4, 0.7) 
3 133.6 5.66 (dd, 16.4, 7.2) 134.5 5.53 (dd, 16.4, 8.5) 134.1 5.70 (dd, 16.4, 6.9) 
4 34.8 2.20 (m) 34.7 2.04 (m) 34.9 2.39 (ddd, 13.9, 7.7, 3.3) 
5 32.0 1.58 (m) 1.63 (m) 33.2 
1.76 (dd, 11.2, 2.3)  
1.08 (dd, 11.2, 4.9) 
33.5 2.34 (m) 1.71 (m) 
6 32.6 1.62 (m) 1.90 (m) 33.3 
1.85 (dd, 9.0, 4.9)  
1.64 (m) 
30.7 1.45 (m) 1.66 (m) 
7 70.2 4.37 (dd, 8.4, 3.5) 76.7 3.95 (dd, 11.4, 4.9) 69.0 5.08 (t, 6.6) 
8 146.2 - 144.8 - 140.1 - 
9 41.0 
2.43 (dd, 13.2, 4.7) 
2.46 (dd, 13.2, 8.9) 
36.5 
2.65 (dd, 13.8, 10.1) 
2.50 (br d, 13.8) 
125.8 5.31 (d, 10.4) 
10 68.6 4.91 (ddd, 8.9, 4.7, 2.4) 70.4 4.88 (ddd, 10.1, 3.2, 2.1) 67.9 5.58 (dd, 10.4, 2.3) 
11 51.1 1.84 (dd, 10.8, 2.4) 50.6 1.94 (dd, 10.5, 3.2) 53.3 1.76 (dd, 10.1, 2.1) 
12 44.2 2.95 (td, 10.8, 4.7) 44.2 3.06 (td, 10.5, 4.9) 44.3 2.98 (m) 
13 26.4 1.95 (m) 1.45 (m) 26.5 1.96 (m) 1.48 (m) 26.2 1.95 (m), 1.46 (m) 
14 38.9 1.46 (m) 1.39 (m) 38.7 1.51 (m) 1.47 (m) 39.2 1.49 (m) 1.39 (m) 
15 16.8 0.83 (s) 18.4 0.83 (s) 16.9 0.93 (s) 
16 22.2 0.97 (d 6.9 ) 21.1 1.00 (d, 6.7) 19.8 0.96 (d, 6.9) 
17 113.5 5.12 (brs) 4.99 (brs) 117.0 5.04 (brs) 4.89 (brs) 17.0 1.66 (d, 1.4) 
18 84.8 - 84.8 - 84.9 - 
19 23.4 1.42 (s) 23.2 1.45 (s) 26.0 1.59 (s) 
20 26.4 1.60 (s) 26.6 1.61 (s) 23.6 1.43 (s) 
21 170.5 - 171.5 - 170.2 - 
22 21.0 2.04 (s) 21.0 2.05 (s) 23.0 1.97 (s) 
23 170.1 - 170.0 - 170.8 - 
24 23.0 1.93 (s) 22.9 1.92 (s) 21.1 2.02 (s) 
Figure 2. 
1
H-
1
H COSY correlations (bold lines) and key H→C HMBC correlations 
(arrows) for compounds (a) 1–2 and (b) 3. 
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Figure 3. Key NOE Correlations for the main conformers found for compounds 1 (a) and 2 (b). 
 
In the case of the epimers 7S* and 7R*, 37 and 23 different conformers were observed, respectively, 
within an energy cutoff of 3 kcal/mol. The conformations identified for the 7S* configuration alone 
were enough to placed protons H-7 and H-10 in a 2 Å environment, which fits the observed NOEs for 
the proposed stereochemistry. The 11,1-trans-fused ring system of the dolabellane was confirmed by 
the carbon chemical shift of CH3-15 at δC 16.8, indicating a 1R* and 11S
*
 configuration [10].  
Finally, the carbon chemical shifts of C-4 methine at δC 34.8 and CH3-16 methyl at δC 22.2  
suggested a 4R* relative configuration, which accorded with other reported compounds [15,17]. 
Hence, compound 1, named dolabelladienol A, was identified as (1R*,2E,4R*,7R*,10S*,11S*, 
12R*)-10,18-diacetoxy-7-hydroxy-2,8(17)-dolabelladiene, resulting in a new natural product. 
The new dolabellane diterpene 2 (6 mg) was also isolated as a white solid. Its molecular formula of 
C24H38O5 was deduced from the [M + Na]
+
 pseudo molecular ion at m/z 429.2627 (C24H38O5Na, ∆1.6) 
and 
13
C NMR spectra (Supplementary Figures S7–S12). The close resemblance between the NMR 
spectra of 1 and 2 (Table 1), including 
1
H-
1
H COSY and HMBC correlations (Figure 2a), indicated 
that 2 shares the same planar structure with 1. However, slight differences in the NMR data of these 
two compounds were observed for the carbon C-7 (δc 70.2, and δc 76.7, respectively) and surrounding 
atoms (Table 1), which indicated that 2 corresponds to the C-7 epimer of 1. 
These findings accord with the NOESY analysis of 2 which demonstrated NOE correlations 
between the H3-15 methyl protons and H-12 and H-10 methine protons, along with the lack of 
correlation between H-7 and H-10 observed in the NOESY spectrum of 1 (Figure 3b). As mentioned 
above, the space-conformational search in a 3.0 kcal/mol range for the epimer 7S, showed all 
conformers with no dipolar correlations between H-7 and the other vicinal protons. The first is located 
in a populated averaged of 4.9 Å away from other proximal protons, and therefore the lack of  
NOE correlations in the NOESY experiment supports the hypothesis that 2 should be the epimer of 1 
at C-7. Thus their stereocenters were assigned as follows 1R*,10S*,11S*,12R*. In this way, 
dolabelladienol A (2) was identified as (1R*,2E,4R*,7S*,10S*,11S*,12R*)10,18-diacetoxy-7-hydroxy-2, 
8(17)-dolabelladiene, and is here reported for the first time. 
Compound 3 (4 mg) was isolated as a white solid, as well, and assigned the molecular formula 
C24H38O5 based on LREIMS analysis (m/z 406 [M]
+
) and 
13
C NMR spectra which required six degrees 
of unsaturation and demonstrated that 3 is an isomer of 1 (Table 1). The NMR data of compound 3 
(Supplementary Figures S13–S17) also showed spectroscopic features for a dolabellane-type diterpene, 
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similar to those of 1 and 2, including the presence of an acetate group at C-18, an acetoxy-bearing 
methine at C-10 and a hydroxyl-bearing methine at C-7. By contrast, the main differences from 1 and 2 
are the absence of chemical signals corresponding to the exocyclic double bond present in 1 and 2 and 
the presence of two endocyclic double bonds at δH 5.70 (dd J = 16.3, 6.9 Hz), 5.31 (d J = 10.4 Hz), and 
5.21 (d J = 16.4 Hz). Assignments of H-C signals of 3 were conducted by HSQC experiments. The  
1
H-
1
H COSY experiment allowed for the establishment of two spins systems that were connected by 
HMBC correlations. In this way, the planar structure of compound 3 could be elucidated as shown  
in Figure 2b. 
The relative stereochemistry of 3 could not be addressed because the compound decomposed. The E 
configuration of Δ2 double bond was established by the J = 16.4 Hz between the olefinic protons  
H2 and H3. Furthermore, the proton and chemical shifts were similar to the compound 
(1R*,2E,4R*,8Z,10S*,11S*,12R*)10,18-diacetoxydolabella-2,8-dien-6-one, reported by Lu and Faulkner 
in 1998, in that they share the same Z configuration at Δ8 double bond [18]. Comparison of the 1H and 
13
C NMR chemical shifts of compound 3 to those of 1 demonstrated that they share the same relative 
configuration for stereocenters at 1, 4, 10, 11 and 12. In this way, we identified and reported for the 
first time the compound 3 as (1R*,2E,4R*,8E,10S*,11S*,12R*)-10,18-diacetoxy-7-hydroxy-2, 
8-dolabelladiene. It is worth noting that compounds 1 or 2 may potentially convert to 3 during the 
course of isolation or purification due to slight acidity. 
Spectral data (
1
H, 
13
C NMR, MS, optical rotation) of compound 4 (30 mg) are the same as those  
of dolabelladienetriol, which was previously isolated from the digestive glands of the sea hare 
Dolabella californica Stearns, 1877 [17] and obtained as semisynthetic product in 2004 [15]. It is 
important to note that this compound has shown strong anti-HIV and anti-HSV activity [2,19]. The 
dolabellanes 5 and 6 of D. pfaffii were also isolated and their spectral data proved identical with those 
of 10,18-diacetoxy-8-hydroxy-2,6-dolabelladiene (5) and 10-acetoxy-8,18-dihydroxy-2,6-dolabelladiene 
(6), which were previously described previously by us in 2004 [15]. We conducted a single crystal X-ray 
diffraction study of the compounds 4 and 5. In the case of compound 4, it was possible to confirm the 
proposed structure, but the results related to compound 5 permitted us an unambiguous description of 
the absolute configuration (Flack parameter = −0.03(6)). Thus, we described the configuration of 
compound 5 as (1R,2E,4R,6E,8S,10S,11S,12R)-8,10,18-diacetoxy-8-hydroxy-2,6-dolabelladiene. 
2.2. Antiviral Activity 
In order to establish the anti-HIV-1 potential of the isolated compounds, we first evaluated the 
safety of compound 1, 2 and 4 for use in human cells by treating MT-2 lymphocytes with various 
concentrations of the test compound. After 4–5 days of treatment, MT-2 viability, determined 
colorimetrically, was higher than 90% for concentrations up to 250 μM, resulting in a CC50 between 
1345 ± 2 and 1456 ± 3.4 μM. It is important to emphasize that the compounds were not cytotoxic and 
were in fact even less toxic than the neviparine (325 μM ± 1.4) used as a control. 
Subsequently, we evaluated the antiviral activity of natural compounds on MT-2 cells at concentrations 
between 6.25 and 25 μM. At 6.25 μM, compounds 1, 2 and 4 inhibited the HIV-1 virus in 83%, 69% 
and 52% of cases, resulting in EC50 values of 2.9 ± 0.2, 4.1 ± 0.4 and 6.16 ± 0.7 μM, respectively. 
There was a slight difference in activity between epimers 1 and 2, but the antiviral activity of the 
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2,8(17)-dolabelladienes series was twice as active as the 2,6-dolabelladienes series and exhibited a 
positive influence on the inhibition of HIV-1. 
It is noteworthy that when compounds 1 and 2 were evaluated in the antiviral test, they proved more 
active than compound 4, hitherto the most active compound reported by us to have demonstrated  
non-competitive inhibition of HIV-1 reverse transcriptase [2,14,15], This suggests that these diterpenes 
could be considered potential new agents for HIV-1 therapy. Therefore, we recommend further studies 
on the precise mechanism of activity and on the in vivo antiviral activity. 
3. Experimental Section 
3.1. General Experimental Procedures 
LREIMS and HRESIMS were measured on QQq-TOF mass spectrometer, Applied Biosystems 
QSTAR Elite. For the HRGC-MS analysis a GC7890A (Agilent Technologies, Santa Clara, CA, USA) 
with a DB-5MS (5% Phenyl methyl siloxane) chromatographic column (60 m × 250 μm × 0.25 μm) 
was coupled with an MSD-5975 (Agilent Technologies) with an electronic impact ion source (70 eV) 
for detecting ions between m/z 50–500 in scan mode. Injector and detector temperatures were set at 
270 °C and 290 °C, respectively. We maintained the temperature program at 160 °C, and then 
programmed to 260 °C at a rate of 4 °C/min before finally raising the temperature at a rate of 10 °C/min 
to 290 °C for 15 min. Helium served as the carrier gas at a flow rate of 1 mL/min. Linear retention 
indices (RI) were calculated according to the Kovats method using a mixture of normal paraffin C6–C26 
as external references. Nuclear magnetic resonance spectra (proton and carbon) were recorded on 
Varian VNMRS or Bruker 500 MHz Advance spectrometers, employing CDCl3 (99.8%, Merck, 
Whitehouse Station, NJ, USA) as a solvent. Multiplicities of 
13
C signals were obtained by DEPT. For 
column chromatography, we used silica gel 60. All the solvents were analytical grade. Optical 
rotations were measured on a Polartronic ADP440+, Bellinghan + Stanley Polarimeter (North Farm 
Industrial Estate, Tunbridge Wells, UK). 
3.2. Sample Collection 
The brown algae Dictyota pfaffii was collected during July 2009 at a depth of 6–9 m, by scuba dives 
at the Atol das Rocas reef, a Biological Marine Reserve in the Rio Grande do Norte State, lat. 
03°51′03″S, long. 33°40′29″W, Brazil. The legal authorization for sample colleting was obtained from 
VLT (SISBIO/IBAMA Brazil) (number 17352). Dr. Roberto Villaça (Departamento de Biologia 
Marinha, Instituto de Biologia, UFF) collected and identified the seaweeds. A voucher specimen  
(HRJ 9117) was deposited in the herbarium of the Universidade do Estado do Rio de Janeiro (UERJ) 
and the seaweed was air-dried. 
3.3. Extraction, Isolation and Structural Elucidation of Compounds 
The air-dried material of Dictyota pfaffii (65 g) was extracted three times with 500 mL of CH2Cl2 
each time for 24 h. The extracts were combined, filtered and further dried under vacuum at 40 °C.  
The dried crude extract (3.5 g) was subjected to vacuum column chromatography (CC) using  
a discontinuous gradient (Hexane/CH2Cl2/EtOAc/MeOH) in order to obtain 12 fractions (F1 to F12). 
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Fraction F7 (CH2Cl2/EtOAc, 9:1) yields white crystals of compound 5 (750 mg). Fraction F8 was 
chromatographed on a silica gel CC using as eluent an isocratic mixture of CH2Cl2/EtOAc, 9:1 in order 
to obtain 12 fractions (F8.1 to F8.12). From these, fraction F8.3 yielded compound 2 (6 mg) and 
compound 3 (4 mg) after silica gel column chromatography eluted with CH2Cl2/EtOAc, 8:2 as solvent. 
Fraction F8.7 yielded the pure compound 6 (20 mg), and fraction F8.10 the pure compound 1 (28 mg). 
Finally, by crystallization in hexane, fraction F10 yielded pure compound 4 (30 mg) in the form of 
white needle crystals. All the isolated compounds were identified the analysis of their 1D- and  
2D-NMR spectra, together with their EI-MS spectra analysis. 
3.4. Conformational Searches 
Conformational searches were performed using 50,000 GMMX steps as implemented in the 
PCmodel software (version 8.5), the MMFF94s force field and the TNCG algorithm. All local minima 
within 3.5 kcal/mol of the global minimum were saved and subsequently re-minimized using the 
FMNR algorithm within an energy cut-off of 3.0 kcal/mol. For compound 1, 15 out of 37 conformers, 
56.9% of the population, exhibited NOE between H-7 and H-10 (distances of 2.11 and 2.96 Å). For 
compound 2, all 23 found conformers, 100% of the population, did not show NOE between H7 and 
H10 (distances larger than 3.8 Å). 
Dolabelladienol A (1R*,2E,4R*,7S*,10S*,11S*,12R*)10,18-diacetoxy-7-hydroxy-2, 
8(17)-dolabelladiene (1). White solid (28 mg), [α]
25
D +11° (c 0.002, CHCl3), RI 2593. 
1
H and 
13
C NMR 
data, see Table 1. EIMS m/z (relative intensity) 406 (4), 346 (3), 304 (4), 286 (100), 271 (46), 243 
(61), 215 (25), 173 (34), 145 (32), 133 (30), 107 (75), 93 (80), 55 (65). HRESIMS: [M + Na]
+
 
429.2631 (C24H38O5Na 429.2611, ∆1.95 mmu). 
Dolabelladienol B (1R*,2E,4R*,7R*,10S*,11S*,12R*)10,18-diacetoxy-7-hydroxy-2, 
8(17)-dolabelladiene (2). White solid, [α]
25
D +4° (c 0.002, CHCl3), RI 2567. 
1
H and 
13
C NMR data, see 
Table 1. HRESIMS 835.5353 [2M + Na]
+
; 429.2627 [M + Na]
+
; EIMS m/z (relative intensity)  
406 [M]
+
 (3), 328 [M – AcOH − H2O]
+
 (5), 304 (7), 286 [M − AcOH − AcOH]+ (45), 243 (43),  
215 (20), 187 (28), 161 (47), 135 (65), 107 (77), 93 (100), 55 (60). 
Dolabelladienol C (1R*,2E,4R*,8E,10S*,11S*,12R*)10,18-diacetoxy-7-hydroxy-2, 
8-dolabelladiene (3). White solid, [α]
25
D +14° (c 0.002, CHCl3), RI 2475. 
1
H and 
13
C NMR data, see 
Table 1 EIMS m/z (relative intensity) 406 (4) 304 (5) 286 (38) 271 (31) 243 (32) 229 (12) 203 (23) 
175 (51) 133 (52) 121 (71) 107 (75) 95 (100) 79 (58) 69 (53) 55 (63). 
(1R*,2E,4R*,6E,8S*,10S*,11S*,12R*)-8,10,18-trihydroxy-2,6-dolabelladiene (4). White needles, 
[α]
25
D −27° (c, 0.5, CHCl3), RI 2257, NMR, and MS data are consistent with literature values [15]. 
(1R,2E,4R,6E,8S,10S,11S,12R)-10,18-diacetoxy-8-hydroxy-2,6-dolabelladiene (5). White needles, 
[α]
25
D −123° (c 0.002, CHCl3), RI 2475, NMR, and MS data are consistent with literature values [15]. 
(1R*,2E,4R*,6E,8S*,10S*,11S*,12R*)-10-acetoxy-8,18-dihydroxy-2,6-dolabelladiene (6). White solid, 
[α]
25
D −70° (c, 0.5, CHCl3), RI 2314, NMR, and MS data are consistent with literature values [15]. 
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3.5. X-Ray Diffraction Analysis of Compound 4 
X-ray diffraction data was carried out in Bruker D8 Venture with radiation CuKα (λ = 1.5418 Å). 
The structure was solved by direct methods and refined by full-matrix least squares on F
2
 with 
SHELX-97 package (Figure 4) [20]. The positions of hydrogen atoms were generated geometrically 
and refined according to a riding model. All non-hydrogen atoms were refined anisotropically. 
Crystallographic data for the structures of 4 and 5 have been deposited with the Cambridge 
Crystallographic Data Centre database. 
Figure 4. X-ray crystal structure of the compound 4 and 5. 
 
Crystallographic data for compound 4: C20H34O3, F.W. = 322.5, colorless needle, monoclinic,  
space group P21, a = 9.4394(7) Å, b = 7.6155(5) Å, c = 13.4810(8) Å, β = 95.527(4)°,  
volume = 964.59(11) Å
3
, Z = 2, Dc = 1.11g/cm
3
, μ = 0.56 mm−1, F(000) = 356, Crystal dimensions: 
0.065 mm × 0.097 mm × 0.268 mm. Independent reflections: 3415 (Rint = 0.058). The final 
anisotropic full-matrix least-squares refinement on F
2
 with 216 variables converged at R1 = 9.73%, for 
the observed data and wR2 = 25, 38% for all data. CCDC number: 1000466. 
Crystallographic data for compound 5: C24H38O5, F.W. = 408.5, colorless prismatic, orthorhombic, 
space group P212121, a = 8.3069(2) Å, b = 13.6440(3) Å, c = 20.7705(5) Å, volume = 2354.11(10) Å
3
, 
Z = 4, Dc = 1.15 g/cm
3
, μ = 0.63 mm−1, F(000) = 888, Crystal dimensions: 0.16 mm × 0.29 mm ×  
0.50 mm. Independent reflections: 4221 (Rint = 0.041). The final anisotropic full-matrix least-squares 
refinement on F
2
 with 267 variables converged at R1 = 3.77%, for the observed data and wR2 = 9.87% 
for all data. The Flack parameter was −0.03 (6) using 1609 quotients [(I+) − (I−)]/[(I+) + (I−)] [21] 
CCDC number: 1005607. 
3.6. Cells and Viruses 
MT-2 cells were grown in RPMI 1640 media (LGC Bio, São Paulo, Brazil), which contained 10%  
heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA). Cell cultures were incubated at 37 °C 
in a humidified air atmosphere containing 5% CO2. HIV-1 isolates IIIB (X4-tropic, subtype B, donated 
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by Eva Maria Fenyo, University of Lund, Lund, Sweden) were prepared in PHA-activated MT-2 cells 
and stored at −70 °C. 
3.7. Cytotoxicity Assays 
The cytotoxicity of the compounds in triplicates was tested in MT-2 cells (2 × 10
6
 cell/100 μL/well) 
grown in 96-well plates for 72 h at 37 °C with a 5% CO2 atmosphere. Cells were incubated with 
culture medium containing the compounds at different concentrations. After 4 to 5 days the HIV-1, 
cytopathic effect was determined colorimetrically by the MTT method [22]. In brief, 20 μL of MTT 
Sigma Chemical Co. (St. Louis, MO, USA) (5 mg/mL) were added to wells and 4 h later the optical 
density was measured at 540 nm. The 50% cytotoxic concentration (CC50) was determinate as the 
concentration capable of reducing the optical density by 50% in comparison with the control. The CC50 
was calculated by linear regression analysis of the dose-response curves generate as previously 
described [23]. 
3.8. Antiviral Assays 
The MT-2 cells (2 × 10
6
 cell/100 μL/well) were initially exposed to viral suspensions containing  
5 to 10 ng/mL of HIV-1 p24 Ag for 2 to 3 h. The cells were treated with compounds at different 
concentrations. After 2–3 days at 37 °C in 5% CO2, HIV-1 cytopathic effect was determined 
colorimetrically by the MTT method [22]. EC50 was calculated as described [23]. The positive control 
was neviparine 5 μM (replication viral inhibition of 99%). 
4. Conclusions 
This study identified four hitherto undescribed dolabellane diterpenes from Dictyota pfaffii (1–4), 
three of which are new (1–3), while one (4) is here described for the first time in this species, in addition 
to the major known compounds 5 and 6. Biological assays demonstrated that none of the compounds 
were cytotoxic. Compounds 1 and 2 were evaluated in the antiviral test and seen to be more active than 
dolabelladienetriol 4 and nevirapine. Such results confirm that these diterpenes should be considered 
as potential new agents for HIV-1 therapy. 
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